Aquatic Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2K Sell
638
-1,387
-68% -$30.7K ﹤0.01% 1262
2025
Q4
$49K Sell
2,025
-32,816
-94% -$859K ﹤0.01% 1260
2025
Q3
$889K Sell
34,841
-23,556
-40% -$559K 0.02% 710
2025
Q2
$1.26M Buy
+58,397
New +$1.32M 0.03% 590
2024
Q4
Sell
-11,600
Closed -$290K 1344
2024
Q3
$290K Hold
11,600
0.01% 746
2024
Q2
$249K Buy
11,600
+7,300
+170% +$142K 0.01% 695
2024
Q1
$79.8K Buy
+4,300
New +$75.2K ﹤0.01% 960
2023
Q2
Sell
-1,500
Closed -$33K 1351
2023
Q1
$33K Sell
1,500
-8,100
-84% -$182K ﹤0.01% 959
2022
Q4
$175K Buy
+9,600
New +$198K 0.01% 765
2022
Q3
Sell
-200
Closed -$3K 1193
2022
Q2
$3K Buy
+200
New +$2.94K ﹤0.01% 1078
2022
Q1
Sell
-3,400
Closed -$127K 1104
2021
Q4
$127K Buy
+3,400
New +$146K 0.25% 89

Other funds holding BLFS

Aquatic Capital Management's BLFS Position: Q1 2026 in Review

Aquatic Capital Management reduced its BioLife Solutions (BLFS) stake by 68% in Q1 2026, selling an estimated $30.7K and leaving 638 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Aquatic Capital Management first reported a position in BLFS in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.26M in Q2 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Aquatic Capital Management held 638 shares of BioLife Solutions worth $12.2K as of Q1 2026.
  • Aquatic Capital Management sold 1,387 BioLife Solutions shares in Q1 2026, an estimated $30.7K.
  • BioLife Solutions made up ﹤0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #1262 holding.
  • Aquatic Capital Management first reported a position in BioLife Solutions in Q4 2021 and has held it in 11 quarters since.
  • Aquatic Capital Management's BioLife Solutions position peaked at $1.26M in Q2 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.